MBO Partenaires acquisition of IMM Recherche

«Potomac Transactions’ agility and in-depth knowledge of the healthcare market have been invaluable in helping us to conclude under the best possible conditions the acquisition of IMMR, a CRO recognized around the globe for its expertise in cardiology »

Cécile Nguyen, Partner of MBO Partenaires

IMMR is a CRO specialized in preclinical research for medical devices.
IMM Recherche was a spin-off of the Montsouris Institute in Paris. In a few years IMMR became a CRO leader in preclinical research for medical devices, more specifically in the cardiovascular sector. The company offers a complete range of services from proof of concept to regulatory studies for FDA, CFDA and CE marking.
In 2016, MBO Partenaires instructed Potomac to advise on the acquisition of IMMR. MBO Partenaires was soon convinced by the unique expertise of IMMR and its opportunity for growth, and structured the best offer for the management and the historical shareholders BTW CAPITAL MANAGEMENT, MATMUT et MGEN.

  • 30 years of experience
  • In 2017, revenues of €12 million
  • 80% of the revenues with international clients
  • 5 operating rooms